Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Equity Ratio: 2020-2025

Historic Equity Ratio for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to 0.08.

  • Oncology Institute's Equity Ratio fell 18682.05% to 0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 19278.04%. This contributed to the annual value of 0.02 for FY2024, which is 9237.54% down from last year.
  • Latest data reveals that Oncology Institute reported Equity Ratio of 0.08 as of Q3 2025, which was down 18682.05% from 0.06 recorded in Q2 2025.
  • Oncology Institute's 5-year Equity Ratio high stood at 0.65 for Q2 2022, and its period low was 0.08 during Q3 2025.
  • Moreover, its 5-year median value for Equity Ratio was 0.22 (2021), whereas its average is 0.27.
  • Its Equity Ratio has fluctuated over the past 5 years, first surged by 38721.77% in 2021, then crashed by 18682.05% in 2025.
  • Quarter analysis of 5 years shows Oncology Institute's Equity Ratio stood at 0.51 in 2021, then dropped by 8.06% to 0.47 in 2022, then plummeted by 42.1% to 0.27 in 2023, then plummeted by 92.38% to 0.02 in 2024, then crashed by 461.01% to 0.08 in 2025.
  • Its Equity Ratio stands at 0.08 for Q3 2025, versus 0.06 for Q2 2025 and 0.03 for Q1 2025.